Velikyan, I.; Bossart, M.; Haack, T.; Laitinen, I.; Estrada, S.; Johansson, L.; Pierrou, S.; Wagner, M.; Eriksson, O.
Imaging of the Glucose-Dependent Insulinotropic Polypeptide Receptor Using a Novel Radiolabeled Peptide Rationally Designed Based on Endogenous GIP and Synthetic Exendin-4 Sequences. Pharmaceuticals 2023, 16, 61.
https://doi.org/10.3390/ph16010061
AMA Style
Velikyan I, Bossart M, Haack T, Laitinen I, Estrada S, Johansson L, Pierrou S, Wagner M, Eriksson O.
Imaging of the Glucose-Dependent Insulinotropic Polypeptide Receptor Using a Novel Radiolabeled Peptide Rationally Designed Based on Endogenous GIP and Synthetic Exendin-4 Sequences. Pharmaceuticals. 2023; 16(1):61.
https://doi.org/10.3390/ph16010061
Chicago/Turabian Style
Velikyan, Irina, Martin Bossart, Torsten Haack, Iina Laitinen, Sergio Estrada, Lars Johansson, Stefan Pierrou, Michael Wagner, and Olof Eriksson.
2023. "Imaging of the Glucose-Dependent Insulinotropic Polypeptide Receptor Using a Novel Radiolabeled Peptide Rationally Designed Based on Endogenous GIP and Synthetic Exendin-4 Sequences" Pharmaceuticals 16, no. 1: 61.
https://doi.org/10.3390/ph16010061
APA Style
Velikyan, I., Bossart, M., Haack, T., Laitinen, I., Estrada, S., Johansson, L., Pierrou, S., Wagner, M., & Eriksson, O.
(2023). Imaging of the Glucose-Dependent Insulinotropic Polypeptide Receptor Using a Novel Radiolabeled Peptide Rationally Designed Based on Endogenous GIP and Synthetic Exendin-4 Sequences. Pharmaceuticals, 16(1), 61.
https://doi.org/10.3390/ph16010061